Astellas Drops Suit Over Medicare Drug Price Negotiation Law

By Theresa Schliep · September 7, 2023, 9:13 PM EDT

Astellas Pharma on Wednesday dropped its challenge to the new Medicare drug price negotiation program after none of its products were selected for negotiation by the U.S. Department of Health and...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Astellas Pharma US, Inc. v. Department of Health and Human Services et al

Case Number

1:23-cv-04578

Court

Illinois Northern

Nature of Suit

440(Civil Rights: Other)

Date Filed

July 14, 2023